Banca Mediolanum (BMED) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
8 Jul, 2026Executive summary
2024 was a record-breaking year with double-digit growth in all key financial metrics, including net income up 36% to €1.12 billion and operating margin up 11%.
Total net inflows reached €10.44 billion (+46%), with managed assets net inflows at €7.64 billion (+91%), and assets under administration/management grew 17% to €138.5 billion.
Customer base expanded 7% to nearly 1.92 million, supported by network expansion and promotional initiatives; Family Bankers network grew 3% to 6,415.
Exceptional performance was driven by both net interest income (+8% to €811.1 million) and a 13% surge in net commission income to €1.17 billion.
Board proposed a €1.00 per share dividend (including €0.25 special dividend), up 42% year-over-year, totaling €737 million.
Financial highlights
Net profit: €1.12 billion (+36% YoY); Operating margin: €1.09 billion (+11%); Contribution margin: €1.98 billion (+12%).
Net commission income: €1.17 billion (+13%); Net interest income: €811.1 million (+8%).
Total net inflows: €10.44 billion (+46%); managed assets net inflows: €7.64 billion (+91%).
Cost/income ratio improved to 39%; cost of risk at 18 basis points.
Total assets reached €138.5 billion (+17% YoY); loans granted €3.1 billion (+4% YoY); credit book €17.62 billion (+3% YoY); net NPE ratio at 0.79%.
General insurance gross premiums rose 11% to €206.1 million.
Outlook and guidance
2025 guidance: net inflows into managed assets expected to match 2024's strong volumes (~€7.5 billion), assuming normal market conditions.
Net interest income projected to decrease by about 5% in 2025, based on current yield curve.
Cost/income ratio targeted below 40%; cost of risk at ~20 basis points.
Base dividend expected to increase, subject to shareholder approval.
CET1 ratio strengthening in anticipation of Basel III implementation in 2025.
Latest events from Banca Mediolanum
- June net inflows reached €951 million, with strong managed asset growth and new client gains.BMED
Trading update9 Jul 2026 - Net income up 6% to €477.3M, with record assets, strong inflows, and robust capital ratios.BMED
Q2 20259 Jul 2026 - Q1 2026 net income up 13% to €276.2M, with strong asset growth and resilient inflows.BMED
Q1 20268 Jul 2026 - Net income up 18% to €674.3M, assets at €133B, CET1 at 23.4%, interim dividend approved.BMED
Q3 20242 Jun 2026 - Net income up 24% to €449.9M, CET1 at 23.7%, and managed asset inflows guidance raised.BMED
Q2 20242 Jun 2026 - Net income up 10–10.4% YoY to €243.3m, with record inflows and strong capital ratios.BMED
Q1 20252 Jun 2026 - Record net income, strong asset growth, and a 25% higher dividend highlight a standout year.BMED
Q4 20253 Feb 2026 - Net income up 8% to €726M, assets at €150.4B, and interim dividend raised to €0.60/share.BMED
Q3 20258 Nov 2025